Sawa Ito, MD Clinical Trial Pipeline: 2 Active Trials, 5 Changes This Month

2

Active Trials

2

Recruiting

5

Disease Areas

5

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-08-12	NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid…	Primary endpoint(s) modified
2026-08-12	NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid…	Trial arms changed: 1 -> 2
2026-07-31	NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid…	Enrollment increased: 45 -> 57 participants
2026-07-31	NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid…	date change Primary completion pushed: 2027-10-31 -> 2029-10-31
2026-07-31	NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid…	date change Completion pushed: 2027-10-31 -> 2029-10-31

Active Trials by Phase

Phase 2

1

Phase 1

1

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT06529731	Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid…	Acute Myeloid Leukemia	Recruiting
Phase 1
NCT07565220	Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for…	Acute Lymphocytic Leukemia (ALL)	Recruiting

Disease Areas

Get alerts when Sawa Ito, MD's trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.